WELCOME TO THE MANUFACTURING REPORT
Newsletter | Member Login | Signup
Home > Companies > GrabCAD
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Additive Manufacturing
Businesswire | May 09, 2023
Stratasys Ltd., a leader in polymer 3D printing, announced today the launch of its new GrabCAD Print Pro software, with integrated quality assurance functionality from Riven, a recent Stratasys acquisition. GrabCAD Print software manages the print preparation process for Stratasys 3D printers. The new Pro version is designed for manufacturers who need to efficiently produce end use parts and move to production-scale volumes. It is specifically designed to improve printed-part accuracy, red...
GrabCAD | July 24, 2020
The Industry 4.0 revolution has changed manufacturing and business processes by introducing cyber-technology systems onto factory floors. Advanced technology such as cloud technology, Industrial Internet of Things (IIoT), artificial intelligence, Big Data, and of course, 3D printers. With these new technologies, manufacturers hope to run their factories smarter than ever before in response to ever changing customers habits and expectations. Stratasys software has joined the Industry 4.0 revoluti...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Article
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE